Stockreport

Immune Pharmaceuticals Announces Acceptance of Abstract at 2018 Pre-IID Pemphigus and Pemphigoid Symposium

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF ENGLEWOOD CLIFFS, NJ -- (Marketwired) -- 03/12/18 -- Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ("Immune" or the "Company") a biopharmaceutical company d [Read more]